Navigation Links
Mindray Medical International Announces Third Quarter 2007 Results
Date:11/1/2007

105,573 250,000 33,365

Other assets 2,124 36,781 4,909

Property, plant and equipment,

net 186,980 315,467 42,103

Land use right 2,505 2,405 321

Intangible assets 149,479 135,357 18,065

Goodwill 122,169 122,169 16,305

Total assets 2,557,123 2,994,846 399,697

LIABILITIES AND SHAREHOLDERS'

EQUITY

Current liabilities:

Notes payable 50,625 58,409 7,795

Accounts payable 79,352 98,578 13,156

Customers' deposits 47,007 37,996 5,071

Salaries payables 55,676 59,323 7,917

Other payables 100,082 105,469 14,076

Income taxes payable 11,703 44,433 5,930

Other taxes payable 7,937 8,729 1,165

Total current liabilities 352,382 412,937 55,111

Commitment and contingencies

Minority interests 11 10 1

Deferred tax liabilities, net 21,815 19,583 2,614

21,826 19,593 2,615

Mezzanine equity:

Convertible redeemable

preferred shares -- --

Shareholders' equity:

Ordinary shares 110 111 15

Additional paid-in capital 1,934,937 2,037,217 271,890

Retained earnings 266,833 578,718 77,237

Accumulated other

comprehensive loss (18,965) (53,730) (7,171)


'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related biology technology :

1. Medical College receives $377K to study brain disease
2. Barriers will not stop convergence of medical technologies
3. Medical College team creates website for tracking flu
4. Biomedical engineering conference invites manufacturers
5. Visions: Wade offers straight talk on e-medical records
6. Merge unveils updated medical imaging software
7. Medical College receives $1.4M cancer grant
8. Medical technology firm lands $100K federal grant
9. Doyle outlines spending for Medical College, UWM
10. And the winners in medical design are
11. Manufacturing partnership will move into biotech and biomedical spaces
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014 Vermillion, Inc. ... on gynecologic disease, announced today that investors including ... Birchview Fund LLC and several Vermillion directors have ... shares of Vermillion,s common stock and warrants to ... a private placement.  Under the ...
(Date:12/24/2014)... LOUIS , Dec. 23, 2014 ... today that the waiting period under the Hart-Scott-Rodino ... the acquisition expired on December 22, 2014, thereby ... review requirement for the acquisition of the Company ... U.S. antitrust clearance satisfies another condition to closing ...
(Date:12/24/2014)... YORK , Dec. 23, 2014  NeuroLifeSciences announced ... mazindol in children with attention deficit/hyperactivity disorder published in ... . The paper, titled "Pilot Phase ... disorder" ( Konofal et al, Drug Des ... ) shows that mazindol might be an effective, ...
(Date:12/22/2014)... Dec. 22, 2014   Synthetic Biologics, ... of pathogen-specific therapies for serious infections and ... microbiome, today announced positive topline safety and ... trial of SYN-004, the Company,s investigational oral ... Clostridium difficile (C. difficile) infection, antibiotic-associated ...
Breaking Biology Technology:Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5
... Hutchings has assumed leadership of Egon Zehnder International,s North ... the practice, will continue at the firm in an ... In his new role, Mr. Hutchings will be ... and providing the full array of functional leadership capabilities ...
... 2010 Clarient, Inc. ("Clarient") (Nasdaq: CLRT ) ... "Offer") by Crane Merger Sub, Inc. ("Purchaser"), an indirect wholly-owned ... GE ) to acquire all of the outstanding shares of ... of the Offer from midnight, New York City time, at ...
... Dec. 3, 2010 Gentiva Health Services, Inc. ... home health and hospice services, announced today that it has ... 2010, at 10:00 a.m. ET to provide an update on ... the morning of December 16 before pre-market trading. ...
Cached Biology Technology:Egon Zehnder International Names Todd Hutchings to Lead Life Sciences Practice Group 2Clarient Tender Offer Extended; Clarient Makes Additional Disclosures to Settle Litigation 2Clarient Tender Offer Extended; Clarient Makes Additional Disclosures to Settle Litigation 3Clarient Tender Offer Extended; Clarient Makes Additional Disclosures to Settle Litigation 4Gentiva® Health Services Schedules 2011 Outlook Conference Call and Webcast for Thursday, December 16, 2010 2Gentiva® Health Services Schedules 2011 Outlook Conference Call and Webcast for Thursday, December 16, 2010 3
(Date:12/10/2014)... 9, 2014     ...   Jifflenow, a ... solutions for business-to-business (B2B) events, today announced a ... mobile near-field communication (NFC), Bluetooth low energy (BLE), ... http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow will integrate its ...
(Date:12/3/2014)... Ariz. , Dec. 2, 2014 As ... hand readers, Inception Technologies is pleased to announce the ... easier for customers to collect the workforce data that ... problems that have been left by existing readers. Many ... user interface, connectivity and modern technology. Older models force ...
(Date:11/21/2014)... 2014   Atmel® Corporation (NASDAQ: ... touch technology solutions, today launched the industry,s first family ... widest V cc range from 1.7V to 5.5V. ... I 2 C bus communication speeds, and are available ... them ideal for consumer, industrial, computer, and medical applications. ...
Breaking Biology News(10 mins):Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Inception Technologies to Release New Biometric Reader 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4
... best friend might just be treated like any other animal ... Blouin, assistant professor of the Department of Sociology and Anthropology ... of animals as children tend to have a city background. ... not uncommon in rural areas," Blouin said, "which makes sense ...
... Carolina State University have developed a method for predicting ... including the human body. Their work could have implications ... handling of nanomaterials, as well as applications for drug ... Wellcome Distinguished Professor of Pharmacology and director of ...
... BIO-key International, Inc. (OTC Bulletin Board: http://photos.prnewswire.com/prnh/20050509/BIOKEYLOGO ) ... What: , BIO-key International, Inc. Second Quarter 2010 ... Thursday, July 29, 2010 - 10:00 a.m. Eastern Time , ... via phone by dialing 800-860-2442 and asking for the BIO-key call at ...
Cached Biology News:Dogs' family status depends on family's locale 2Probing the nanoparticle: Predicting how nanoparticles will react in the human body 2BIO-key® Announces Second Quarter 2010 Earnings Release and Conference Call Schedule 2BIO-key® Announces Second Quarter 2010 Earnings Release and Conference Call Schedule 3
... to ATP-binding proteins. To create this ... was linked through the Gamma-thiol of ... use for binding studies the BODIPY ... new substrate for Fhit a member ...
... Using information-rich MSn data, the ... of multiple levels of fragmentation, isotope ... techniques to accurately determine the correct ... Traditional approaches for deducing empirical formulae ...
... custom peptide synthesis with a wide variety of ... your research needs. Purity: IG(>50%), ... 2mg-1g Sequence Length: Up to ... N-acetylation, C-amidation, phosphorylation, D-amino acids, MAPs, KLH/BSA conjugation, ...
... 50 mg/L streptomycin sulfate, 100 mg/L kanamycin ... magnesium chloride. The use of a balanced ... generally attributed to early workers in the ... solution of inorganic salts designed to maintain ...
Biology Products: